Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24


All cholesterol-lowering interventions are expected to reduce stroke: Confirmatory data from IMPROVE-IT.

De Caterina R, Salvatore T, Marchioli R.

Data Brief. 2016 Apr 27;7:1541-50. doi: 10.1016/j.dib.2016.04.059. eCollection 2016 Jun.


Decreasing cholesterol levels in the community--lifestyle change with statin?

Savolainen J, Kautiainen H, Niskanen L, Mäntyselkä P.

BMC Fam Pract. 2015 Feb 28;16:29. doi: 10.1186/s12875-015-0240-y.


Dietary fatty acids in the secondary prevention of coronary heart disease: a systematic review, meta-analysis and meta-regression.

Schwingshackl L, Hoffmann G.

BMJ Open. 2014 Apr 19;4(4):e004487. doi: 10.1136/bmjopen-2013-004487. Review.


Increasing fruit and vegetable consumption: challenges and opportunities.

Sachdeva S, Sachdev TR, Sachdeva R.

Indian J Community Med. 2013 Oct;38(4):192-7. doi: 10.4103/0970-0218.120146. No abstract available.


Effects of Brazilian Cardioprotective Diet Program on risk factors in patients with coronary heart disease: a Brazilian Cardioprotective Diet randomized pilot trial.

Weber B, Galante AP, Bersch-Ferreira AC, Torreglosa CR, Carvalho VO, Victor Eda S, Espírito-Santo JA, Ross-Fernandes MB, Soares RM, Costa RP, Lara Ede S, Buehler AM, Berwanger O.

Clinics (Sao Paulo). 2012 Dec;67(12):1407-14.


A Comparison of Selenium Concentrations between Congestive Heart Failure Patients and Healthy Volunteers.

Ghaemian A, Salehifar E, Shiraj H, Babaee Z.

J Tehran Heart Cent. 2012 Spring;7(2):53-7. Epub 2012 May 31.


Misconduct accounts for the majority of retracted scientific publications.

Fang FC, Steen RG, Casadevall A.

Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):17028-33. doi: 10.1073/pnas.1212247109. Epub 2012 Oct 1. Erratum in: Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):1137.


Clinical and economic considerations of antiobesity treatment: a review of orlistat.

Zohrabian A.

Clinicoecon Outcomes Res. 2010;2:63-74. Epub 2010 Jul 5.


Reduced or modified dietary fat for preventing cardiovascular disease.

Hooper L, Summerbell CD, Thompson R, Sills D, Roberts FG, Moore H, Davey Smith G.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD002137. doi: 10.1002/14651858.CD002137.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;5:CD002137.


Omega-3 fatty acids and cardiovascular disease: The epidemiological evidence.

Simopoulos AP.

Environ Health Prev Med. 2002 Jan;6(4):203-9. doi: 10.1007/BF02897971.


Suspected research fraud: difficulties of getting at the truth.

White C.

BMJ. 2005 Jul 30;331(7511):281-8. No abstract available.


Investigating allegations of scientific misconduct.

Smith J, Godlee F.

BMJ. 2005 Jul 30;331(7511):245-6. No abstract available.


Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women.

Mozaffarian D, Rimm EB, Herrington DM.

Am J Clin Nutr. 2004 Nov;80(5):1175-84. Erratum in: Am J Clin Nutr. 2005 Jan;81(1):199.


Drugs used in secondary prevention after myocardial infarction: case presentation.

Maxwell S, Waring WS.

Br J Clin Pharmacol. 2000 Nov;50(5):405-17. Review. No abstract available.


Improvements in chronic diseases with a comprehensive natural medicine approach: a review and case series.

Nader T, Rothenberg S, Averbach R, Charles B, Fields JZ, Schneider RH.

Behav Med. 2000 Spring;26(1):34-46. Review.


Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States.

Ascherio A, Rimm EB, Giovannucci EL, Spiegelman D, Stampfer M, Willett WC.

BMJ. 1996 Jul 13;313(7049):84-90.


Cholesterol lowering and mortality: the importance of considering initial level of risk.

Smith GD, Song F, Sheldon TA.

BMJ. 1993 May 22;306(6889):1367-73. Erratum in: BMJ 1993 Jun 19;306(6893):1648.


Modification of atherosclerosis by agents that do not lower cholesterol.

Cleland JG, Krikler DM.

Br Heart J. 1993 Jan;69(1 Suppl):S54-62. Review. No abstract available.

Items per page

Supplemental Content

Support Center